Procter & Gamble Company (The) (NYSE:PG) Given Average Rating of “Moderate Buy” by Analysts

Shares of Procter & Gamble Company (The) (NYSE:PGGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-three research firms that are presently covering the stock, MarketBeat reports. Ten research analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $171.7619.

Several equities analysts have recently issued reports on PG shares. UBS Group lowered their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Berenberg Bank boosted their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. JPMorgan Chase & Co. upped their price target on shares of Procter & Gamble from $163.00 to $165.00 and gave the company a “neutral” rating in a report on Monday, October 27th. Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a report on Monday. Finally, Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th.

View Our Latest Report on PG

Procter & Gamble Stock Performance

PG stock opened at $147.71 on Thursday. The company has a 50-day simple moving average of $147.53 and a 200 day simple moving average of $153.78. The company has a market capitalization of $345.15 billion, a P/E ratio of 21.56, a PEG ratio of 4.88 and a beta of 0.39. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. Procter & Gamble has a fifty-two week low of $138.14 and a fifty-two week high of $179.99.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. Procter & Gamble’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the company earned $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Sell-side analysts predict that Procter & Gamble will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s payout ratio is presently 61.75%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares in the company, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the transaction, the chief operating officer owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 30,308 shares of company stock worth $4,611,852 in the last three months. Insiders own 0.20% of the company’s stock.

Institutional Trading of Procter & Gamble

A number of hedge funds have recently modified their holdings of PG. Halbert Hargrove Global Advisors LLC acquired a new position in Procter & Gamble during the third quarter valued at $25,000. Nova Wealth Management Inc. purchased a new position in Procter & Gamble during the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC increased its holdings in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares during the period. Saranac Partners Ltd acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at about $30,000. Finally, Corundum Trust Company INC purchased a new stake in shares of Procter & Gamble in the third quarter worth approximately $32,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.